EMILY ARNDT: Open Payments
NPI 1184308520 · FLORA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 26 payments from 12 companies in 2025. Trend: 2023 $91 · 2024 $151 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $109 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $62 |
| Novo Nordisk Inc | 3 | $60 |
| Insulet Corporation | 2 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: CAPLYTA, JOURNAVX, FARXIGA, BREZTRI, Omnipod, GVOKE HYPOPEN, GEMTESA, JARDIANCE.
Industry payments across IL — which companies pay providers there.
